223 related articles for article (PubMed ID: 14524289)
1. [Anti-leukotrienes in allergic diseases in children].
Jung A
Pol Merkur Lekarski; 2003 Jun; 14(84):631-3. PubMed ID: 14524289
[TBL] [Abstract][Full Text] [Related]
2. Treatment of asthma with antileukotrienes: first line or last resort therapy?
Dahlén SE
Eur J Pharmacol; 2006 Mar; 533(1-3):40-56. PubMed ID: 16510137
[TBL] [Abstract][Full Text] [Related]
3. Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis.
Banasiak NC; Meadows-Oliver M
Pediatr Nurs; 2005; 31(1):35-8. PubMed ID: 15794321
[No Abstract] [Full Text] [Related]
4. Leukotriene modifiers in pediatric asthma management.
Bisgaard H
Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
[TBL] [Abstract][Full Text] [Related]
5. [Leukotriene modifiers in the treatment of asthma].
Alvarez J
Rev Alerg Mex; 1999; 46(3):72-7. PubMed ID: 10425884
[TBL] [Abstract][Full Text] [Related]
6. [The role of leukotrienes in inflammation and leukotriene inhibitors].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene receptor antagonists.
Altinger JA
Lippincotts Prim Care Pract; 1998; 2(6):634-42. PubMed ID: 9883158
[No Abstract] [Full Text] [Related]
8. [Leukotriene modifiers].
Minoguchi K; Adachi M
Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
[TBL] [Abstract][Full Text] [Related]
9. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene antagonism in asthma and rhinitis.
Lane SJ
Respir Med; 1998 Jun; 92(6):795-809. PubMed ID: 9850362
[No Abstract] [Full Text] [Related]
11. Leukotriene antagonists and inhibitors: clinical applications.
Ford-Hutchinson AW
Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():69-74. PubMed ID: 7732907
[No Abstract] [Full Text] [Related]
12. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
13. Asthma therapy with agents preventing leukotriene synthesis or action.
Drazen JM
Proc Assoc Am Physicians; 1999; 111(6):547-59. PubMed ID: 10591083
[TBL] [Abstract][Full Text] [Related]
14. The role of antileukotrienes in asthma management.
Tan RA
Curr Opin Pulm Med; 1998 Jan; 4(1):25-30. PubMed ID: 9526901
[TBL] [Abstract][Full Text] [Related]
15. Antileukotrienes in asthma: present situation.
García-Marcos L; Schuster A
Expert Opin Pharmacother; 2001 Mar; 2(3):441-66. PubMed ID: 11336598
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
Steinke JW; Culp JA
Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
[TBL] [Abstract][Full Text] [Related]
17. Antileukotrienes and asthma: alternative or adjunct to inhaled steroids?
Kavuru MS; Subramony R; Vann AR
Cleve Clin J Med; 1998; 65(10):519-26. PubMed ID: 9830785
[TBL] [Abstract][Full Text] [Related]
18. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
Fal AM; Kopeć A
Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
[TBL] [Abstract][Full Text] [Related]
19. [Antileukotrienes. Their use in pediatrics].
Garde Garde Jf; Haro E; Sanchez-Lucas C; Garde Noguera J
Allergol Immunopathol (Madr); 2000; 28(3):136-43. PubMed ID: 10867384
[TBL] [Abstract][Full Text] [Related]
20. New treatments for asthma: the role of leukotriene modifier agents.
Valacer DJ
J Natl Med Assoc; 1999 Aug; 91(8 Suppl):26S-39S. PubMed ID: 12653390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
